The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 8.00
Ask: 8.48
Change: 0.00 (0.00%)
Spread: 0.48 (6.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.00
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Aug 2018 16:46

RNS Number : 1840Z
Oxford BioDynamics PLC
29 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biodynamics plc

2138005Y1TK258O5U928

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

 

A decrease in percentage ownership of the issuer's shares as a result of an increase in the issuer's issued share capital

X

3. Details of person subject to the notification obligationiv

Name

Alexandre Akoulitchev

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

28 August 2018

6. Date on which issuer notified (DD/MM/YYYY):

29 August 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6,153,082

-

6.67%

92,201,306

Position of previous notification (if

applicable)

6,153,082

-

7.03%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BD5H8572

6,153,082

6.67%

SUBTOTAL 8. A

6,153,082

6.67%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Oxford, UK

Date of completion

28 August 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEASPNALDPEFF
Date   Source Headline
11th Apr 202212:00 pmRNSHolding(s) in Company
8th Apr 202210:40 amRNSPDMR Dealing
7th Apr 202210:36 amRNSPDMR Dealing
6th Apr 20224:14 pmRNSPDMR Dealing
6th Apr 20224:03 pmRNSPDMR Dealing
30th Mar 20222:09 pmRNSResults of Annual General Meeting
4th Mar 20229:42 amRNSPDMR Dealing
3rd Mar 20229:58 amRNSPDMR Dealing
1st Mar 20224:16 pmRNSPUBLICATION OF 2021 ANNUAL REPORT
25th Feb 20227:00 amRNSUS launch of EpiSwitch® CiRT for oncology
15th Feb 202210:17 amRNSPDMR Dealing
10th Feb 202211:52 amRNSPDMR Dealing
8th Feb 20223:10 pmRNSHolding(s) in Company
7th Feb 20222:47 pmRNSPDMR Dealing
26th Jan 20229:50 amRNSPDMR Dealing
25th Jan 202211:44 amRNSPDMR Dealing
25th Jan 20227:00 amRNSFinal Results
19th Jan 20229:58 amRNSHolding(s) in Company
14th Jan 20222:36 pmRNSHolding(s) in Company
14th Jan 20227:00 amRNSHolding(s) in Company
13th Jan 202212:00 pmRNSHolding(s) in Company
11th Jan 20229:00 amRNSHolding(s) in Company
10th Jan 20227:02 amRNSHolding(s) in Company
4th Jan 20227:00 amRNSHolding(s) in Company
29th Dec 20214:00 pmRNSHolding(s) in Company
24th Dec 202111:40 amRNSPDMR Dealing
23rd Dec 20217:00 amRNSNotice of Results
17th Dec 20217:00 amRNSOBD updates on EpiSwitch CST and CiRT tests
13th Dec 20212:23 pmRNSHolding(s) in Company
13th Dec 202110:12 amRNSPDMR Dealing
1st Dec 202112:00 pmRNSPDMR Dealing
24th Nov 20213:02 pmRNSPDMR Dealing
22nd Nov 202111:00 amRNSPDMR Dealing
18th Nov 20213:16 pmRNSHolding(s) in Company
18th Nov 20213:10 pmRNSPDMR Dealing
18th Nov 202111:53 amRNSHolding(s) in Company
11th Nov 202111:08 amRNSResults of General Meeting
4th Nov 20217:00 amRNSHolding(s) in Company
2nd Nov 202112:22 pmRNSHolding(s) in Company
1st Nov 202112:43 pmRNSTotal Voting Rights
1st Nov 20217:00 amRNSHolding(s) in Company
25th Oct 20212:45 pmRNSOBD raises £3.62 million
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSChange of Registered Office
31st Aug 20217:00 amRNSOxford BioDynamics awarded US FNIH Grant
15th Jun 20211:06 pmRNSPDMR Dealing
15th Jun 20217:00 amRNSHalf-year Report
27th May 20219:00 amRNSNotice of Results
14th May 202110:17 amRNSPDMR Dealing / Grant of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.